Talk to Us

Anthem Blue Cross and Blue Shield Virginia policies, page 8

Search Anthem Blue Cross and Blue Shield Virginia's public medical, payment and drug policies by CPT or HCPCS code, keyword or policy number, with links to the payer's own documents. Links open the payer's own document; check its current version before relying on it.

555 public policies Substrate tracks for Anthem Blue Cross and Blue Shield Virginia, by title.

Anthem Blue Cross and Blue Shield Virginia policies
PolicyDetailsCodesSource
MED.00110 Silver-based Products for Wound and Soft Tissue ApplicationsMED.00110 · Commercial1Original policy ↗
MED.00111 Intracardiac Ischemia MonitoringMED.00111 · Commercial9Original policy ↗
MED.00116 Near-Infrared Spectroscopy Scanning for Brain Hematoma ScreeningMED.00116 · Commercial1Original policy ↗
MED.00118 Continuous Monitoring of Intraocular PressureMED.00118 · Commercial1Original policy ↗
MED.00120 Gene Therapy for Ocular ConditionsMED.00120 · Commercial5Original policy ↗
MED.00129 Gene Therapy for Spinal Muscular AtrophyMED.00129 · Commercial2Original policy ↗
MED.00130 Surface Electromyography and Electrodermal Activity Sensor Devices for Seizure MonitoringMED.00130 · Commercial3Original policy ↗
MED.00131 Electronic Home Visual Field Monitoring MED.00131 · Commercial2Original policy ↗
MED.00132 Autologous Adipose-derived Regenerative Cell TherapyMED.00132 · Commercial8Original policy ↗
MED.00133 Ingestion Event MonitorsMED.00133 · Commercial2Original policy ↗
MED.00135 Gene Therapy for HemophiliaMED.00135 · Commercial6Original policy ↗
MED.00137 Eye Movement Analysis Using Non-spatial Calibration for the Diagnosis of ConcussionMED.00137 · Commercial1Original policy ↗
MED.00138 Wearable Devices for Stress Relief and Management MED.00138 · Commercial2Original policy ↗
MED.00139 Electrical Impedance Scanning for Cancer DetectionMED.00139 · Commercial1Original policy ↗
MED.00140 Gene Therapy for Beta Thalassemia MED.00140 · Commercial5Original policy ↗
MED.00142 Gene Therapy for Cerebral AdrenoleukodystrophyMED.00142 · Commercial4Original policy ↗
MED.00143 Ingestible Devices for the Treatment of ConstipationMED.00143 · Commercial2Original policy ↗
MED.00146 Gene Therapy for Sickle Cell DiseaseMED.00146 · Commercial5Original policy ↗
MED.00148 Gene Therapy for Metachromatic LeukodystrophyMED.00148 · Commercial4Original policy ↗
MED.00150 Hepzato Kit™ (melphalan hepatic delivery system)MED.00150 · Commercial2Original policy ↗
MED.00151 Gene Therapy for Aromatic L-Amino Acid Decarboxylase DeficiencyMED.00151 · Commercial4Original policy ↗
MED.00152 Outpatient Intravenous Insulin TherapyMED.00152 · Commercial1Original policy ↗
Medicare Advantage 2017 Precertification RequirementsEffective Jan 1, 2017 · CA, CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, VA, WI132Original policy ↗
Medicare Advantage 2018 Precertification RequirementsEffective Jan 1, 2018 · CA, CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, VA, WI158Original policy ↗
Medicare Advantage Precertification Requirements – 2019CA, CO, CT, GA, IN, KY, ME, MO, NH, NV, OH, VA, WI191Original policy ↗
Medicare Advantage Provider ManualMULTI-BCBS-CR-PM-065801-24-CPN65783 · Effective Jan 1, 2025 · Medicaid · VA—Original policy ↗
Medicare Supplement System Consolidation FAQs59396MUPENMUB · Commercial · VA—Original policy ↗
Modifier 22 – ProfessionalC-12003 · Effective Dec 1, 2025 · Commercial · VA—Original policy ↗
Modifier 26 and TC: Professional and Technical Component - ProfessionalC-20004 · Effective Oct 1, 2021 · Commercial · VA—Original policy ↗
Modifier 62 – ProfessionalC-21005 · Effective Mar 1, 2025 · Commercial · VA—Original policy ↗
Modifier 66 - ProfessionalC-21006 · Effective Mar 1, 2025 · Commercial · VA—Original policy ↗
Modifier FB - Professional and FacilityC-22003 · Effective Mar 1, 2023 · Commercial · VA—Original policy ↗
Modifier Usage – ProfessionalC-08010 · Effective Mar 1, 2025 · Commercial · VA12Original policy ↗
Modifiers 25 and 57: Evaluation and Management Services with Global Procedures - ProfessionalC- 09011 · Effective Mar 1, 2025 · Commercial · VA8Original policy ↗
Modifiers 50 and 51: Multiple and Bilateral Surgery - ProfessionalC-08004 · Effective Mar 1, 2025 · Commercial · VA55Original policy ↗
Modifiers 59 and XE, XP, XS, & XU: Distinct Procedural Service - ProfessionalC-09006 · Effective Mar 1, 2025 · Commercial · VA113Original policy ↗
Modifiers 80, 81, 82 and AS: Assistant at Surgery – ProfessionalC-08006 · Effective Mar 1, 2025 · Commercial · VA42Original policy ↗
Module 1 PDSA ExampleCommercial · CT, GA, NH, VA—Original policy ↗
Module 2 PDSA ExampleCommercial · CT, GA, NH, VA—Original policy ↗
Module 3 PDSA ExampleCommercial · CT, GA, NH, VA—Original policy ↗
Molecular Signature Test for Predicting Response to Tumor Necrosis Factor Inhibitor TherapyLAB.00042 · Commercial1Original policy ↗
MRI Guided High Intensity Focused Ultrasound Ablation for Non-Oncologic IndicationsMED.00057 · Commercial6Original policy ↗
Multiple Delivery Services - ProfessionalC-19005 · Effective Mar 1, 2023 · Commercial · VA—Original policy ↗
Multiple Diagnostic Imaging Procedures – ProfessionalC-11004 · Effective Dec 1, 2023 · Commercial · VA—Original policy ↗
Multiple Procedure Payment Reduction – ProfessionalC-23003 · Effective Dec 1, 2023 · Commercial · VA—Original policy ↗
Multiplex Autoantigen Microarray Testing for Systemic Lupus ErythematosusLAB.00036 · Commercial2Original policy ↗
Near-Infrared Coronary Imaging and Near-Infrared Intravascular Ultrasound Coronary ImagingRAD.00057 · Commercial1Original policy ↗
Non-invasive Cardiac Management and Monitoring SystemsMED.00134 · Commercial5Original policy ↗
Nurse Practitioner and Physician Assistant Services - ProfessionalC-20001 · Effective Mar 1, 2023 · Commercial · VA—Original policy ↗
OB/GYN Referral Preparedness Tool (Blank Template)Commercial · CT, GA, NH, VA—Original policy ↗

Back to Anthem Blue Cross and Blue Shield Virginia · Anthem Blue Cross and Blue Shield Virginia prior authorization CPT list

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.

This website uses cookies to ensure you get the best experience on our website. Learn more